General and Specific Considerations as to why Osteoporosis-Related Care Is Often Suboptimal

Autor: Elizabeth M Curtis, Claire Holmes, Stephen J Woolford, Cyrus Cooper, Nicholas C. Harvey
Rok vydání: 2020
Předmět:
0301 basic medicine
medicine.medical_specialty
Health Knowledge
Attitudes
Practice
Epidemiology
Endocrinology
Diabetes and Metabolism
Cost-Benefit Analysis
Osteoporosis
030209 endocrinology & metabolism
Risk Assessment
Reimbursement Mechanisms
03 medical and health sciences
0302 clinical medicine
Absorptiometry
Photon
Secondary Prevention
Medicine
Humans
In patient
Adverse effect
Intensive care medicine
Reimbursement
Quality of Health Care
Quality of Care in Osteoporosis (S Silverman and J Curtis
Section Editors)
Fragility fracture
Bone Density Conservation Agents
Treatment gap
business.industry
Adverse effects
Health Policy
Multimorbidity
Guideline
medicine.disease
3. Good health
Primary Prevention
Fracture
Policy
Practice Guidelines as Topic
Bisphosphonate-Associated Osteonecrosis of the Jaw
030101 anatomy & morphology
Clinical Competence
Guideline Adherence
business
Femoral Fractures
Osteoporotic Fractures
Screening measures
Zdroj: Current Osteoporosis Reports
ISSN: 1544-2241
Popis: Purpose of Review The assessment of fracture risk and use of antiosteoporosis medications have increased greatly over the last 20–30 years. However, despite this, osteoporosis care remains suboptimal worldwide. Even in patients who have sustained a fragility fracture, fewer than 20% actually receive appropriate antiosteoporosis therapy in the year following the fracture. There is also evidence that treatment rates have declined substantially in the last 5–10 years, in many countries. The goal of this article is to consider the causes for this decline and consider how this situation could be remedied. Recent Findings A number of possible reasons, including the lack of prioritisation of osteoporosis therapy in ageing populations with multimorbidity, disproportionate concerns regarding the rare side effects of anti-resorptives and adverse changes in reimbursement in the USA, have been identified as contributing factors in poor osteoporosis care. Summary Improved secondary prevention strategies; screening measures (primary prevention) and appropriate, cost-effective guideline and treatment threshold development could support the optimisation of osteoporosis care and prevention of future fractures.
Databáze: OpenAIRE
Externí odkaz: